![Enno Spillner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enno Spillner
Finanzdirektor/CFO bei
FORMYCON AG
Vermögen: 146 800 $ am 30.06.2026
Profil
Derzeit ist Enno Spillner Chief Financial Officer der Evotec SE und Co-Geschäftsführer der Evotec International GmbH (einer Tochtergesellschaft der Evotec SE). Außerdem ist er im Vorstand der Nanobiotix SA und der Concentro Management AG sowie Managing Partner bei der Biom Venture Capital GmbH & Co. Fonds KG. In seiner bisherigen beruflichen Laufbahn war Enno Spillner als Chief Executive & Financial Officer der 4SC AG, als Geschäftsführer der Munich Innovative Biomaterials GmbH, als Geschäftsführer der ActiPac Biosystems GmbH und als Head-Finance & Controlling der BioM AG Munich BioTech Development tätig. Enno Spillner absolvierte ein MBA-Studium an der Universität Bamberg.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NANOBIOTIX SA 0.01% | 31.03.2026 | 4’000 ( 0.01% ) | 146 800 $ | 30.06.2026 |
Aktive Positionen von Enno Spillner
| Unternehmen | Position | Beginn |
|---|---|---|
| NANOBIOTIX | Direktor/Vorstandsmitglied | 18.06.2014 |
| FORMYCON AG | Finanzdirektor/CFO | 01.04.2023 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Provides financial consulting services | Direktor/Vorstandsmitglied | 11.05.2010 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Direktor/Vorstandsmitglied | - |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Direktor/Vorstandsmitglied | 01.01.2014 |
Ehemalige bekannte Positionen von Enno Spillner
| Unternehmen | Position | Ende |
|---|---|---|
| EVOTEC SE | Finanzdirektor/CFO | 01.03.2023 |
| 4SC AG | Vorstandsvorsitzender | 30.06.2016 |
ActiPac Biosystems GmbH | Vorstandsvorsitzender | 01.03.2000 |
Munich Innovative Biomaterials GmbH
 Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Vorstandsvorsitzender | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Enno Spillner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
University of Bamberg
 University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biom Venture Capital GmbH & Co. Fonds KG
 Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Provides financial consulting services | Finance |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Finance |
